AVORO CAPITAL ADVISORS LLC

Adviser information for AVORO CAPITAL ADVISORS LLC last updated from Form ADV on March 5th, 2024. Select data displayed; additional Form ADV, Form D, Form 13F and other data is available from the Fincoded API.

Advisory Business

Type of Organization Limited Liability Company
Fiscal Year End DECEMBER
Legal Location Delaware, United States

Employees

Total Number of Employees 15
Investment Advisory/Research 10
Registered Broker-Dealer Representatives 0
Registered State Investment Advisers 0
Licensed Agents of an Insurance Company 0
No. of Firms/People that Solicit Clients 0

RAUM

Provides Management of Securities Portfolios Yes
Type Accounts RAUM
Discretionary 3 $8.7B
Non-Discretionary 0 $0
Total 3 $8.7B

Clients

Type Number RAUM
Individuals 0 $0
HNW Individuals 0 $0
Banking or thrift institutions 0 $0
Investment companies 0 $0
Business development companies 0 $0
Pooled investment vehicles 3 $8.7B
Pension and profit sharing plans 0 $0
Charitable organizations 0 $0
State or municipal gov entities 0 $0
Other investment advisers 0 $0
Insurance companies 0 $0
Sovereign wealth funds and foreign official institutions 0 $0
Corporations or other businesses 0 $0
Other 0 $0
Type Number
No. of Non-RAUM Clients 0
No. of Non-U.S. Clients 33

Services

Advisory Services Portfolio management for pooled investment vehicles
Compensation % of AUMPerformance-based fees
Other Business Activities Commodity pool operator or commodity trading advisor

Identifiers

SEC RIA File Number 801-74391
SEC ERA File Number 801-74391
SEC CIK Numbers 1633313
SEC CRD Numbers 154091
Legal Entity Identifier None

Principal Office

110 GREENE STREET
SUITE 800
NEW YORK
NY
United States
Monday - Friday, 8AM - 6PM
Tel: 212-937-4970, Fax: 646-757-2710

Chief Compliance Officer

SCOTT EPSTEIN
CHIEF COMPLIANCE OFFICER
110 GREENE STREET
SUITE 800
NEW YORK
NY
United States
Tel: 212-937-4975
Fax: 646-757-2710
(Full email address available in API data)

Industry Affiliates

AVORO VENTURES GP LLC Sponsor, GP, manager of pooled investment vehicles

Private Funds

Name Type Assets $USD Min Investment $USD No. Owners
AVORO LIFE SCIENCES FUND LLC Hedge Fund $8,572.1M $1.0M 405
AVORO VENTURES FUND L.P. Venture Capital Fund $165.8M $5.0M 48

Control Persons

Name Type Entity Title Since Ownership
AGHAZADEH, BEHZAD Individual MANAGING DIRECTOR 09/2017 < 5%
EPSTEIN, SCOTT, ANDREW Individual CHIEF FINANCIAL OFFICER AND CHIEF COMPLIANCE OFFICER 06/2014 < 5%
AVORO CAPITAL L.P. Domestic Entity DIRECT OWNER 05/2019 > 75%
AGHAZADEH, BEHZAD Individual AVORO CAPITAL L.P. LIMITED PARTNER 05/2019 50-75%
AGHAZADEH, BEHZAD Individual AVORO CAPITAL GP LLC MEMBER 05/2019 50-75%
AVORO CAPITAL GP LLC Domestic Entity AVORO CAPITAL L.P. GENERAL PARTNER 05/2019
KONG, GARHENG, ALBERT Individual AVORO CAPITAL GP LLC MEMBER 05/2019 50-75%

No. Employees, Historic

2010020192020202120222023202420259 on 5/13/20199 on 9/6/201911 on 3/10/202011 on 6/29/202013 on 3/23/202115 on 3/15/202216 on 3/10/202315 on 3/5/2024

RAUM, Historic

9B5B020192020202120222023202420252249047783 on 5/13/20192249047783 on 9/6/20194700635769 on 3/10/20204700635769 on 6/29/20207418631144 on 3/23/20216465626043 on 3/15/20227777370092 on 3/10/20238737904424 on 3/5/2024

No. Clients, Historic

105020192020202120222023202420252 on 5/13/20192 on 9/6/20192 on 3/10/20202 on 6/29/20203 on 3/23/20213 on 3/15/20223 on 3/10/20233 on 3/5/2024

Holdings

From latest 13F, filed August 14th, 2024 for period ending June 30th, 2024
Name Class Value $USD # Shares Private Fund
AADI BIOSCIENCES INC Common 4M 3M
ADVERUM BIOTECHNOLOGIES INC Common 3M 417K
ALNYLAM PHARMCEUTICALS INC. Common 97M 400K
AMICUS THERAPEUTICS INC. Common 272M 27M
APELLIS PHARMACEUTICALS INC. Common 426M 11M
ARGENX SE Sponsored ADR 533M 1M
ARROWHEAD PHARMACEUTICALS INC. Common 231M 9M
ASCENDIS PHARMA Sponsored ADR 572M 4M
AUTOLUS THERAPEUTICS PLC Sponsored ADR 43M 12M
AVIDITY BIOSCIENCES INC Common 266M 7M
BICYCLE THERAPEUTICS PLC Sponsored ADR 14M 700K
BIOCRYST PHARMACEUTICALS INC Common 78M 13M
BIOMARIN PHARMACEUTICAL INC Common 375M 5M
CEREVEL THERAPEUTICS HLDNG Common 308M 8M
CG ONCOLOGY INC Common 22M 700K
DYNE THERAPEUTICS INC. Common 4M 116K
INTRA-CELLULAR THERAPIES INC Common 205M 3M
IOVANCE BIOTHERAPEUTICS INC Common 94M 12M
KRYSTAL BIOTECH INC Common 447M 2M
KURA ONCOLOGY INC Common 73M 4M
KYMERA THERAPEUTICS INC Common 116M 4M
MADRIGAL PHARMACEUTICALS INC Common 576M 2M
MANNKIND CORP Common 46M 9M
MERUS N V Common 80M 1M
MONTE ROSA THERAPEUTICS INC Common 17M 5M
MOONLAKE IMMUNOTHERAPEUTICS CLASS A ORD 122M 3M
NEUROGENE INC Common 802K 22K
OCULAR THERAPEUTIX INC Common 55M 8M
SAREPTA THERAPEUTICS INC Common 474M 3M
SOLENO THERAPEUTICS INC Common 85M 2M
SPDR SERIES TRUST - S&P BIOTECH ETF 281M 3M
SPYRE THERAPEUTICS INC Common 43M 2M
SYNDAX PHARMACEUTICALS INC Common 80M 4M
TAYSHA GENE THERAPIES INC Common 42M 19M
TOURMALINE BIO INC Common 29M 2M
ULTRAGENYX PHARMACEUTICAL INC Common 34M 830K
UNITED THERAPEUTICS CORP Common 911M 3M
VAXCYTE INC Common 43M 575K
VERA THERAPEUTICS INC Common 156M 4M
VERRICA PHARMACEUTICALS INC Common 29M 4M
XENON PHARMACEUTICALS INC Common 221M 6M